Dietary Fish Intake and Incident Atrial Fibrillation (from the Women's Health Initiative)

American Journal of Cardiology

Volumn 105, Issue 6, 2010, Pages 844-848

  Berry, Jarett D ^a   Prineas, Ronald J ^b   van Horn, Linda ^c   Passman, Rod ^c   Larson, Joseph ^d   Goldberger, Jeffrey ^c   Snetselaar, Linda ^e   Tinker, Lesley ^d   Liu, Kiang ^c   Lloyd Jones, Donald M ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ELECTROCARDIOGRAPHY; FEMALE; FISH; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE;

AGED; ANIMALS; ATRIAL FIBRILLATION; DIET; FATTY ACIDS, OMEGA-3; FEMALE; FISHES; HUMANS; MIDDLE AGED;

EID: 77649271714     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.039     Document Type: Article

References (20)

1. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., and Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96 (1997) 2455-2461
2. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271 (1994) 840-844
3. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., D'Agostino R.B., Massaro J.M., Beiser A., Wolf P.A., and Benjamin E.J. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (2004) 1042-1046
4. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32 (1998) 695-703
5. Poole-Wilson P.A., Swedberg K., Cleland J.G.F., Di Lenarda A., Hanrath P., Komajda M., Lubsen J., Lutiger B., Metra M., Remme W.J., Torp-Pedersen C., Scherhag A., and Skene A. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
6. Wang T.J., Larson M.G., Levy D., Vasan R.S., Leip E.P., Wolf P.A., D'Agostino R.B., Murabito J.M., Kannel W.B., and Benjamin E.J. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003) 2920-2925
7. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
8. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
9. Mozaffarian D., Psaty B.M., Rimm E.B., Lemaitre R.N., Burke G.L., Lyles M.F., Lefkowitz D., and Siscovick D.S. Fish intake and risk of incident atrial fibrillation. Circulation 110 (2004) 368-373
10. Calo L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E., Meo A., Pandozi C., Staibano M., and Santini M. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45 (2005) 1723-1728
11. Sakabe M., Shiroshita-Takeshita A., Maguy A., Dumesnil C., Nigam A., Leung T.-K., and Nattel S. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 116 (2007) 2101-2109
12. Sarrazin J.-F., Comeau G., Daleau P., Kingma J., Plante I., Fournier D., and Molin F. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 50 (2007) 1505-1512
13. Brouwer I.A., Heeringa J., Geleijnse J.M., Zock P.L., and Witteman J.C. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation: the Rotterdam study. Am Heart J 151 (2006) 857-862
14. Frost L., and Vestergaard P. N-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81 (2005) 50-54
15. Women's Health Initiative Study Group. Design of the Women's Health Initiative: clinical trial and observational study. Control Clin Trials 19 (1998) 61-109
16. Patterson R.E., Kristal A.R., Tinker L.F., Carter R.A., Bolton M.P., and Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 9 (1999) 178-187
17. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., and Siscovick D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107 (2003) 1372-1377
18. Rautaharju P.M., Kooperberg C., Larson J.C., and LaCroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative. Circulation 113 (2006) 473-480
19. Rautaharju P.M., Park L.P., Chaitman B.R., Rautaharju F., and Zhang Z.-M. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocard 31 (1998) 157-187
20. London B., Albert C., Anderson M.E., Giles W.R., Van Wagoner D.R., Balk E., Billman G.E., Chung M., Lands W., Leaf A., McAnulty J., Martens J.R., Costello R.B., and Lathrop D.A. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop. Circulation 116 (2007) e320-e335